Research

A nurse-driven quality improvement initiative at Fox Chase Cancer Center has dramatically reduced same-day chemotherapy infusion cancellations, improved patient education and experience, and generated significant cost savings.

Physicians from the Fox Chase-Temple Urologic Institute will present new research and clinical insights at the 2026 American Urological Association Annual Meeting, where they will highlight advances in kidney cancer treatment, penile prosthesis surgery, and the management of prolonged priapism.

Fox Chase researchers developed a new tool that helps clinicians understand whether the tissue surrounding a pancreatic tumor is helping fight the cancer or allowing it to grow. In the lab, the team found that a specialized form of radiation treatment can change the tumor environment to potentially work against the cancer.

A Fox Chase Cancer Center study using young, middle‑aged and geriatric mice suggests melanoma incidence and mortality are strongly age‑dependent and that age‑related immune changes can promote aggressive melanoma spread, particularly in middle age.

Researchers at Fox Chase Cancer Center have demonstrated that extending postoperative blood clot prevention medication for patients undergoing DIEP flap breast reconstruction significantly reduces the risk of venous thromboembolism (VTE), a potentially life-threatening complication.

Researchers at Fox Chase Cancer Center have uncovered a new mechanism by which the body’s immune system responds to viral infections, a finding that can potentially be harnessed to attack cancer.

Researchers at Fox Chase Cancer Center were part of an international team that found a steep rise in kidney cancer cases will be driven largely by preventable risk factors such as obesity, smoking, lack of exercise, diabetes, and hypertension.

Researchers at Fox Chase Cancer Center have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with esophageal cancer and non-small cell lung cancer.